We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Albemarle (ALB) Moves 16.3% Higher: Will This Strength Last?
Read MoreHide Full Article
Albemarle (ALB - Free Report) shares soared 16.3% in the last trading session to close at $215.62. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 11.8% gain over the past four weeks.
ALB’s shares surged on a sharp spike in lithium prices globally. Lithium prices have rebounded from trough levels in 2025, supported by tighter supply and strong demand in China and globally. A surge in lithium prices, thanks to strong demand from electric vehicles and energy storage systems, along with supply disruptions due to recent supply reductions in China, is expected to drive ALB’s performance.
This specialty chemicals company is expected to post quarterly earnings of $1.00 per share in its upcoming report, which represents a year-over-year change of +655.6%. Revenues are expected to be $1.29 billion, up 19.7% from the year-ago quarter.
Earnings and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements.
For Albemarle, the consensus EPS estimate for the quarter has been revised 2.7% higher over the last 30 days to the current level. And a positive trend in earnings estimate revision usually translates into price appreciation. So, make sure to keep an eye on ALB going forward to see if this recent jump can turn into more strength down the road.
Albemarle belongs to the Zacks Chemical - Diversified industry. Another stock from the same industry, Stepan Co. (SCL - Free Report) , closed the last trading session 1.2% higher at $50.79. Over the past month, SCL has returned 10.8%.
Stepan Co.'s consensus EPS estimate for the upcoming report has remained unchanged over the past month at $0.32. Compared to the company's year-ago EPS, this represents a change of -61.9%. Stepan Co. currently boasts a Zacks Rank of #5 (Strong Sell).
Zacks' 7 Best Strong Buy Stocks (New Research Report)
Valued at $99, click below to receive our just-released report
predicting the 7 stocks that will soar highest in the coming month.
View the Zacks #1 Rank List
Image: Bigstock
Albemarle (ALB) Moves 16.3% Higher: Will This Strength Last?
Albemarle (ALB - Free Report) shares soared 16.3% in the last trading session to close at $215.62. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 11.8% gain over the past four weeks.
ALB’s shares surged on a sharp spike in lithium prices globally. Lithium prices have rebounded from trough levels in 2025, supported by tighter supply and strong demand in China and globally. A surge in lithium prices, thanks to strong demand from electric vehicles and energy storage systems, along with supply disruptions due to recent supply reductions in China, is expected to drive ALB’s performance.
This specialty chemicals company is expected to post quarterly earnings of $1.00 per share in its upcoming report, which represents a year-over-year change of +655.6%. Revenues are expected to be $1.29 billion, up 19.7% from the year-ago quarter.
Earnings and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements.
For Albemarle, the consensus EPS estimate for the quarter has been revised 2.7% higher over the last 30 days to the current level. And a positive trend in earnings estimate revision usually translates into price appreciation. So, make sure to keep an eye on ALB going forward to see if this recent jump can turn into more strength down the road.
The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
Albemarle belongs to the Zacks Chemical - Diversified industry. Another stock from the same industry, Stepan Co. (SCL - Free Report) , closed the last trading session 1.2% higher at $50.79. Over the past month, SCL has returned 10.8%.
Stepan Co.'s consensus EPS estimate for the upcoming report has remained unchanged over the past month at $0.32. Compared to the company's year-ago EPS, this represents a change of -61.9%. Stepan Co. currently boasts a Zacks Rank of #5 (Strong Sell).